Lv634
1986 积分 2024-03-31 加入
Real‐world effectiveness and safety of treatment strategies for unresectable, driver‐negative Stage III NSCLC : A retrospective multicentre study
1天前
待确认
Combined stereotactic radiotherapy and immunotherapy improves survival in driver-gene-negative NSCLC patients with brain oligo-metastases: a multicenter real-world study
1天前
待确认
[Chinese Guidelines for the diagnosis, treatment, prophylaxis and management of pulmonary thromboembolism (2025 edition)]
6天前
已完结
Cardiovascular Safety of Inhaled Long-Acting Bronchodilators in Individuals With Chronic Obstructive Pulmonary Disease
9天前
已关闭
Could Single-Inhaler Triple Therapy Be At Increased Risk of Major Adverse Cardiovascular Events in COPD?
9天前
已关闭
[Chinese Guidelines for the diagnosis, treatment, prophylaxis and management of pulmonary thromboembolism (2025 edition)]
12天前
已完结
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial
12天前
已完结
New Onset Pruritus Following Discontinuation of Cetirizine or Levocetirizine
13天前
已关闭
Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β2-agonist bronchodilators
16天前
已完结
Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations
17天前
已完结
皖公网安备34019202002308
